Professional Documents
Culture Documents
Objectives
To define Diabetes Mellitus and enumerate its different classifications for the pediatric population To describe the etiology, pathophysiology and clinical manifestations of the major classifications of Diabetes Mellitus To describe the laboratory work-up and management of Diabetes Mellitus To enumerate the different complications of Diabetes Mellitus
Diabetes Mellitus
Chronic, metabolic syndrome Hyperglycemia cardinal biochemical feature Heterogeneous group of disorders Incidence: (US) 1: 400 children and adolescents Incidence: (Type 1, Philippines) 0.41: 100,000
Diagnostic criteria
IMPAIRED GLUCOSE TOLERANCE (IGT) Fasting glucose 110125 mg/dL (6.1 7.0 mmol/L) DIABETES MELLITUS (DM) Symptoms of DM plus random plasma glucose 200 mg/dL (11.1 mmol/L) or
2-hr plasma glucose during the OGTT 140 mg/dl but <200 mg/dL (11.1 mmol/L)
Etiologic Classification
Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus Other specific types
Genetic defects of -cell function Genetic defects in insulin action Diseases of the exocrine pancreas Endocrinopathies Drug-or chemical-induced Infections Uncommon forms of immune-mediated diabetes Other genetic syndromes sometimes associated with diabetes
Type 1 - Etiology
Genetic susceptibility
FOXP3 gene, AIRE gene Major histocompatibility complex (MHC) class II genes Insulin gene locus
Environmental factors
Viral infections Diet Psychological stress
Type 2 - Etiology
A polygenic disease aggravated by environmental factors Has a strong genetic component but genetic basis is complex and incompletely defined
TCF7L2 PPARG KCNJ11
Type 1 - Pathophysiology
Type 2 - Pathophysiology
Symptoms of ketoacidosis
Dehydration, Kussmaul respiration, fruity breath odor, changes in sensorium
Type 1 Work-up
Blood glucose levels
Fasting: 126mg/dl Random: 200 mg/dl
Urinalysis: glucose, ketones, albumin HbA1c Lipid profile Work-up for Diabetic ketoacidosis: ABG, electrolytes Screening for complications
Type 2 Work-up
Blood glucose levels
Fasting: 126mg/dl Random: 200
Goals of treatment
Maintain a balance between tight glucose control and avoiding hypoglycemia To eliminate polyuria and nocturia To prevent ketoacidosis To permit normal growth and development with minimal effect on lifestyle
Type 1 - Management
Subcutaneous Insulin
Type 1 - Management
Type 1 - Management
Other routes of insulin
Insulin pump therapy Oral and inhaled insulin
Type 2 - Management
Glucosidase inhibitors
Biguanides Thiazolinediones
Biguanides Thiazolinediones
Type 1 - Complications
Type 2 - Complications